These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21598469)

  • 1. [Experience with 125I brachytherapy as a radical treatment for prostate cancer at the Russian X-ray Radiology Research Center].
    Kaprin AD; Milenin KN; Ivanov SA; Tsybul'skiĭ AD; Gerasimov AA
    Vestn Rentgenol Radiol; 2011; (1):26-8. PubMed ID: 21598469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors in the outcome of 125I brachytherapy as monotherapy for prostate cancer.
    Hinnen KA; van Vulpen M
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):115-23. PubMed ID: 21166516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis.
    Polascik TJ; Pound CR; DeWeese TL; Walsh PC
    Urology; 1998 Jun; 51(6):884-9; discussion 889-90. PubMed ID: 9609622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen relapse-free survival and side-effects in 734 patients with up to 10 years of follow-up with localized prostate cancer treated by permanent iodine implants.
    Prada PJ; Juan G; González-Suárez H; Fernández J; Jimenez I; Amón J; Cepeda M
    BJU Int; 2010 Jul; 106(1):32-6. PubMed ID: 20067460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brachytherapy of 125I implantation for localized prostate cancer (report of 41 cases)].
    Bai Q; Wang Y; Kaye KW
    Zhonghua Nan Ke Xue; 2004 May; 10(5):371-3. PubMed ID: 15190833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience.
    Henry AM; Al-Qaisieh B; Gould K; Bownes P; Smith J; Carey B; Bottomley D; Ash D
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):50-6. PubMed ID: 20005453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer.
    Ramos CG; Carvalhal GF; Smith DS; Mager DE; Catalona WJ
    J Urol; 1999 Apr; 161(4):1212-5. PubMed ID: 10081871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive 125I prostate brachytherapy implant for low-risk prostate cancer in a patient with an ileal pouch-anal anastomosis: a case report.
    Miles EF; Nelson JW
    Brachytherapy; 2011; 10(2):117-20. PubMed ID: 20688577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
    International Commission on Radiological Protection
    Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy.
    Frank SJ; Levy LB; Kuban DA; Lee AK; Kudchadker RJ; Bruno TL; van Vulpen M; Swanson DA
    J Urol; 2009 Apr; 181(4):1658-63; discussion 1663-4. PubMed ID: 19233434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brachytherapy in prostatic adenocarcinoma].
    Haie-Meder C; Court B; Perrin JL; Wibault P; Lartigau E; Gerbaulet A
    Ann Urol (Paris); 1994; 28(6-7):295-301. PubMed ID: 7893114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK; Adams MT; Motta J
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
    Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
    BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience.
    Torres-Roca JF; Cantor AB; Shukla S; Montejo ME; Friedland J; Seigne JD; Heysek R; Pow-Sang J
    Urol Oncol; 2006; 24(5):384-90. PubMed ID: 16962486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.
    Potters L; Cha C; Oshinsky G; Venkatraman E; Zelefsky M; Leibel S
    Cancer J Sci Am; 1999; 5(5):301-6. PubMed ID: 10526671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005.
    Colberg JW; Decker RH; Khan AM; McKeon A; Wilson LD; Peschel RE
    Cancer J; 2007; 13(4):229-32. PubMed ID: 17762756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.